Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bitopertin + SSRI in OCD
NCT01674361Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2012
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bitopertin in obsessive compulsive disorder (OCD), sponsored by Roche. Started Dec 2012; status: completed.
02
Drugs
bitopertin
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT01674361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01674361.